Elsevier Inc.

SHERPA: Unknown

People

  1. Abu-Rustum
    Abu-Rustum
  2. Deasy
    Deasy
  3. Adusumilli
    Adusumilli
  4. Thor
    Thor
  5. Giralt
    Giralt
  6. Jones
    Jones
  7. Hultcrantz
    Hultcrantz
  8. Leitao
    Leitao
  9. Scordo
    Scordo
  10. Shah
    Shah

Groups

  1. Sloan Kettering Institute Postdocs (1173)
  2. Department of Medicine (452)
  3. GSK Faculty (362)
  4. Surgery (352)
  5. Survivorship Research (328)
  6. Graduate Medical Education (271)
  7. Radiation Oncology, Department of (250)
  8. Solid Tumor Oncology Division (244)
  9. Department of Pathology and Laboratory Medicine (222)
  10. Hematologic Malignancies, Division of (222)
Search Within
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (524)
  2. Journal Article (523)
  3. Review (72)
  4. Book Section (22)
  5. Editorial (12)
  6. Correspondence (9)
  7. Research Letter (5)
  8. Conference Paper (4)
  9. Guidelines (2)
Groups
  1. Sloan Kettering Institute Postdocs (1173)
  2. Department of Medicine (452)
  3. GSK Faculty (362)
  4. Surgery (352)
  5. Survivorship Research (328)
  6. Graduate Medical Education (271)

More Groups

People
  1. Nadeem Abu-Rustum (84)
  2. Joseph Deasy (83)
  3. Prasad Adusumilli (74)
  4. Maria Thor (73)
  5. Andreas Rimner (72)
  6. Sergio Giralt (68)

More People

Years
  1. 2025 (29)
  2. 2024 (138)
  3. 2023 (116)
  4. 2022 (121)
  5. 2021 (106)
  6. 2020 (94)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (222)
  2. Journal of Thoracic Oncology (133)
  3. Gynecologic Oncology (96)
  4. Clinical Lymphoma, Myeloma and Leukemia (68)
  5. Biology of Blood and Marrow Transplantation (65)
  6. Radiotherapy and Oncology (54)

More Publications

Results (1173)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Network topology analysis reveals unique multiple myeloma genomic subtypes and potential new therapeutic targets
    Meeting Abstract

    Simhal, A.; Maclachlan, K.; Elkin, R.; Zhu, J.; Usmani, S.; Deasy, J. O.; Oh, J. H.; Tannenbaum, A.
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Evaluating serum free light chain ratio as a biomarker for multiple myeloma
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • African American patients with smoldering multiple myeloma may have a lower risk of progression compared to white patients
    Meeting Abstract

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Lu, S.; Patel, D.; Shah, U.; Tan, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: A retrospective study of 34 patients highlighting the need for consensus criteria
    Meeting Abstract

    Pianko, M. J.; Tiutan, T.; Derkach, A.; Jaffer-Sathick, I.; Rossi, A.; Salvatore, S.; Landau, H.; Lahoud, O.; Korde, N.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Pathogenic germline mutations in a large cohort of multiple myeloma
    Meeting Abstract

    Conry, M.; Camp, N.; Vachon, C.; Slager, S.; Hildebrandt, M.; Brown, E.; Garber, J.; Norman, A.; Stokes, S.; Lipkin, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Maintenance therapy cessation for patients with three-year sustained MRD negative remissions: Initial results from a phase II study
    Meeting Abstract

    Korde, N.; Diamond, B.; Burge, M.; Hassoun, H.; Landau, H.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Shah, U.; Maclachlan, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Clinical and translational results of the myeloma developing regimens using genomics (MyDRUG) sub-protocol C1 targeting RAS mutations
    Meeting Abstract

    Kumar, S.; Jayasinghe, R.; Bianchi, G.; Biran, N.; Hultcrantz, M.; Richter, J.; Vij, R.; Ye, C.; Zonder, J.; DeLello, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Evidence-based guidelines increase uptake and decrease racial disparities in endometrioid endometrial cancer patients electing ovarian preservation
    Meeting Abstract

    Manning-Geist, B.; Rios-Doria, E.; Aviki, E.; Zhou, Q.; Abu-Rustum, N.; Brown, C.; Mueller, J.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • What matters most in FIGO IIIA endometrial cancer: Involvement of serosa, adnexa, or both?
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Glaser, G.; McGree, M.; Eriksson, A. G. Z.; Pham, M.; Soliman, P.; Ataseven, B.; Alektiar, K.; Zamarin, D.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Sentinel lymph node biopsy compared with systematic lymphadenectomy in patients with uterine carcinosarcoma
    Meeting Abstract

    Zammarrelli, W.; Greenman, M.; Rios-Doria, E.; Miller, K.; Broach, V.; Mueller, J.; Aviki, E.; Abu-Rustum, N.; Leitao, M.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save